NIH-funded research R01 grant

Investigating a new signaling pathway in alcoholic liver disease

Official title: A novel cholinergic circuitry in alcoholic liver disease (NIAAA)

Funded at University of Michigan at Ann Arbor · NIH-11018509 · Data updated 2026-11-12

This study is looking at how a new way that liver cells talk to immune cells might help protect the liver from damage caused by drinking alcohol, and it's aimed at finding new treatments for people with alcoholic liver disease.

More Alcoholic Liver Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startMarch 15, 2021
Project endJanuary 31, 2026
Funding year2025
Award (this year)$371,967
NIH project number5R01AA028761-05
Project IDNIH-11018509 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with alcoholic liver disease or those at risk of developing liver damage due to alcohol consumption.

Less likely to help

Patients with liver disease not related to alcohol consumption may not benefit from this research.

What this research studies

This research explores a newly discovered cholinergic signaling pathway in the liver that may play a protective role against damage caused by alcohol consumption. The study focuses on how immune cells in the liver communicate with liver cells through acetylcholine, particularly in the context of alcoholic liver disease (ALD). Researchers will use advanced techniques, including flow cytometry, to analyze liver cells from specially bred mice after alcohol exposure. The goal is to understand the mechanisms behind liver damage and identify potential therapeutic targets for ALD.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for alcoholic liver disease, improving outcomes for patients suffering from this condition.

How similar studies have gone: While the specific cholinergic signaling pathway being investigated is novel, similar approaches have shown promise in understanding liver diseases and developing new therapies.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Wu, Jun — University of Michigan at Ann Arbor
  • Study coordinator: Wu, Jun

Related research

Other NIH-funded projects on the same topics.

  • Microbiome and Innate Immune Response in Alcohol-Related Liver Disease

    Researchers are studying how gut bacteria and the body's first-line immune defenses contribute to liver damage from alcohol, with a focus on how a specific bacteria and its toxins affect disease severity.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11543368

  • Lipotoxicity and Alcohol-Related Liver Disease

    This project studies how fatty acids cause liver cell damage in alcohol-related liver disease to help develop new treatments.

    NIH research University of North Carolina Greensboro · Greensboro, United States · NIH-11450399

  • NNMT as a Target to Treat Alcoholic Liver Disease

    A study to see if blocking an enzyme called NNMT can help people with alcoholic liver disease.

    NIH research University of Illinois at Chicago · Chicago, UNITED STATES · NIH-11380807

  • How gut fungi may drive alcohol-related liver damage

    Researchers are looking at whether specific fungi in the gut make liver damage from heavy drinking worse in people with alcohol-related liver disease.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11378956

  • Heat shock protein 90 and alcohol-related liver disease: how macrophages fuel inflammation

    This project looks at how a cellular stress protein, HSP90, affects liver inflammation in people with alcohol-related liver disease by focusing on macrophages.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11374847

  • Why alcohol-related liver disease can come back after a transplant

    Looking at whether an enzyme called CerS6 helps fat build up in the liver and whether measuring CerS6 can help detect or predict return of alcohol-related liver disease before or after a liver transplant.

    NIH research University of Washington · Seattle, United States · NIH-11329541

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.